If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGOG.L Regulatory News (GOG)

  • There is currently no data for GOG

Form 8.3 - Go-Ahead Group plc, The

10 Aug 2022 12:56

RNS Number : 5891V
Barclays PLC
10 August 2022
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

GO-AHEAD GROUP PLC, THE

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of

offeror/offeree:

(e)

Date position held/dealing undertaken:

09 Aug 2022

(f)

In addition to the company in 1(c) above, is the discloser making

NO

disclosures in respect of any other party to the offer?

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

to which the disclosure relates following the dealing(if any)

Class of relevant security:

10p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1)

Relevant securities owned

and/or controlled:

729,051

1.69%

62,977

0.15%

(2)

Cash-settled derivatives:

and/or controlled:

5,999

0.01%

405,011

0.94%

(3)

Stock-settled derivatives (including options)

and agreements to purchase/sell:

0

0.00%

0

0.00%

TOTAL:

735,050

1.70%

467,988

1.08%

(b)

Rights to subscribe for new securities (including directors and other executive

options)

Class of relevant security in relation to

which subscription right exists

Details, including nature of the rights

concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Class of relevant

Purchase/sale

Number of

Price per unit

security

securities

10p ordinary

Purchase

30

15.3500 GBP

10p ordinary

Purchase

50

15.3208 GBP

10p ordinary

Purchase

243

15.3400 GBP

10p ordinary

Purchase

504

15.3625 GBP

10p ordinary

Purchase

1,056

15.3371 GBP

10p ordinary

Purchase

2,407

15.3218 GBP

10p ordinary

Sale

11

15.3345 GBP

10p ordinary

Sale

26

15.3400 GBP

10p ordinary

Sale

163

15.3391 GBP

10p ordinary

Sale

169

15.3600 GBP

10p ordinary

Sale

1,460

15.3274 GBP

(b)

Cash-settled derivative transactions

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

reference

unit

security

securities

10p ordinary

SWAP

Long

5

15.3360 GBP

10p ordinary

SWAP

Long

6

15.3333 GBP

10p ordinary

SWAP

Long

26

15.3398 GBP

10p ordinary

SWAP

Long

169

15.3600 GBP

10p ordinary

SWAP

Long

713

15.3198 GBP

10p ordinary

SWAP

Long

747

15.3347 GBP

10p ordinary

SWAP

Short

120

15.3200 GBP

10p ordinary

SWAP

Short

383

15.3612 GBP

10p ordinary

CFD

Short

504

15.3625 GBP

10p ordinary

SWAP

Short

553

15.3251 GBP

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

date

money

relevant

selling,

securities

per unit

paid/

security

varying etc

to which

received

option

per unit

relates

(ii)

Exercising

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

securities

unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

(c)

Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

10 Aug 2022

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETBBGDISUBDGDG
Date   Source Headline
20th Jan 202112:46 pmRNSEmployee Benefit Trust Share Purchase
14th Jan 20213:14 pmRNSDirector/PDMR Shareholding
8th Jan 20215:26 pmRNSHolding(s) in Company
4th Jan 20219:00 amRNSBlock listing Interim Review
23rd Dec 20203:42 pmRNSHolding(s) in Company
23rd Dec 20207:00 amRNSHolding(s) in Company
22nd Dec 202011:59 amRNSEmployee Benefit Trust Share Purchase
18th Dec 20205:29 pmRNSDirector/PDMR Shareholding
18th Dec 20202:40 pmRNSDirector/PDMR Shareholding
3rd Dec 20207:00 amRNSGo-Ahead trading update
24th Nov 20204:39 pmRNSResult of AGM
24th Nov 20203:21 pmRNSHolding(s) in Company
20th Nov 20204:31 pmRNSDirector/PDMR Shareholding
20th Nov 20204:12 pmRNSEmployee Benefit Trust Share Purchase
20th Nov 20204:06 pmRNSDirector/PDMR Shareholding
13th Nov 20204:20 pmRNSDirector/PDMR Shareholding
29th Oct 20207:37 amRNSHolding(s) in Company
27th Oct 20204:58 pmRNSHolding(s) in Company
15th Oct 20203:57 pmRNSAnnual Report and Accounts / AGM
13th Oct 20205:58 pmRNSDirector/PDMR Shareholding
2nd Oct 202011:49 amRNSDirector/PDMR Shareholding
24th Sep 20207:00 amRNSGo-Ahead: Full year results 2020
21st Sep 20207:00 amRNSNew GTR contract to run to September 2021
15th Sep 20202:22 pmRNSDirector/PDMR Shareholding
1st Sep 20207:51 amRNSHolding(s) in Company
26th Aug 20207:00 amRNSSingapore bus contract extension
14th Aug 20202:52 pmRNSDirector/PDMR Shareholding
13th Aug 20208:02 amRNSHolding(s) in Company
10th Aug 20207:00 amRNSThe Go-Ahead Group plc - regional bus funding
6th Aug 20207:00 amRNSFull year results date change
14th Jul 20201:14 pmRNSDirector/PDMR Shareholding
8th Jul 20209:34 amRNSHolding(s) in Company
1st Jul 202010:33 amRNSBlock listing Interim Review
15th Jun 20205:01 pmRNSDirector/PDMR Shareholding
29th May 20205:08 pmRNSHolding(s) in Company
22nd May 20207:00 amRNSTrading Statement
13th May 20202:47 pmRNSDirector/PDMR Shareholding
28th Apr 20204:10 pmRNSDisclosure of rights attached to equity shares
22nd Apr 202012:01 pmRNSHolding(s) in Company
21st Apr 20204:01 pmRNSDirector/PDMR Shareholding
20th Apr 20207:00 amRNSEmployee Benefit Trust Share Purchase
15th Apr 20203:45 pmRNSDirector/PDMR Shareholding
3rd Apr 20207:00 amRNSRegional Bus Funding
31st Mar 20207:12 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSSoutheastern Direct Award Contract
23rd Mar 20207:04 amRNSStatement on the coronavirus (COVID-19)
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:37 pmRNSPrice Monitoring Extension
17th Mar 20209:50 amRNSEmployee Benefit Trust Share Purchase
16th Mar 20204:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.